Categories AlphaGraphs, Earnings, LATEST

Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits

Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales of biosimilar insulin glargine in the US, despite rise in research & development expenses. The drug maker reported Rs 84 crore net profit in the corresponding period of previous year. Total revenues rose 23% YoY to Rs 2,217 crore in Q1FY23, compared to Rs 1,808 in Q1FY22.

The earnings before interest, tax, depreciation and amortization (EBITDA) grew 9% YoY to Rs 478 crore in Q1FY23 and EBITDA margins dropped 200 basis points to 22%. Biocon Biologics share which constitutes 45% of revenues reported 29% YoY growth to Rs Rs 977 crore in Q1FY23, while the generic business rose 19% to Rs 580 Cr.

Dr Arun Chandavarkar, managing director of Biocon Biologics said the company has initiated global clinical trials for two monoclonal antibodies and advanced its other pipeline assets which led to a 120% increase in R&D investments this quarter.

“Whilst this impacts EBITDA in the near term, such investments will create a strong portfolio to secure our future growth,” Chandravarkar said.

“Our strategic alliance with Serum Institute Life Sciences for vaccines and the acquisition of Viatris’ global biosimilars business are on track for closure in the second half of this calendar year,” he added.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top